Table 2 Clinical characteristics of patients with COVID-19 on admission
From: Risk factors for disease progression in COVID-19 patients
Variable | Total | Cured Group | Transferred Group | P-value |
|---|---|---|---|---|
Total, n (%) | 211 (100%) | 198 (93.8%) | 13 (6.2%) | |
Age, years | 37.55 ± 14.53 | 36.47 ± 14.04 | 54.08 ± 11.98 | .000* |
Sex, n (%) | ||||
Female | 137 (64.9%) | 129 (65.2%) | 8 (61.5%) | .791 |
Male | 74 (35.1%) | 69 (34.8%) | 5 (38.5%) | |
Initial vital sign & symptoms | ||||
Body temperature (°C) | 37.09 ± 4.85 | 37.04 ± 0.42 | 37.81 ± 0.76 | .003* |
Oxygen saturation (%) | 97.20 ± 11.88 | 97.24 ± 11.93 | 96.57 ± 9.76 | .096 |
Chills | 22 (10.4%) | 16 (8.1%) | 6 (46.2%) | .000* |
Cough | 92 (43.6%) | 83 (41.9%) | 9 (69.2%) | .054 |
Myalgia | 44 (20.9%) | 35 (17.7%) | 9 (69.2%) | .000* |
Sputum | 66 (31.3%) | 59 (29.8%) | 7 (53.8%) | .070 |
Rhinorrhea | 58 (27.5%) | 52 (26.3%) | 6 (46.2%) | .120 |
Sore throat | 46 (21.8%) | 43 (21.7%) | 3 (23.1%) | .908 |
Headache | 53 (25.1%) | 47 (23.7%) | 6 (46.2%) | .071 |
Diarrhea | 33 (15.6%) | 30 ((1.5%) | 3 (23.1%) | .446 |
Dyspnea | 26 (12.3%) | 21 (10.6%) | 5 (38.5%) | .003* |
Chest pain | 24 (11.4%) | 22 (11.1%) | 2 (15.4%) | .643 |
Findings of pneumonia in chest X-ray | 54 (25.6%) | 43 (21.7%) | 11 (84.6%) | .000* |
Comorbidities | ||||
Hypertension | 13 (6.2%) | 9 (4.5%) | 4 (30.8%) | .000* |
Diabetes | 4 (1.9%) | 1 (0.5%) | 3 (23.1%) | .000* |
Chronic kidney disease | 0 (0%) | 0 (0%) | 0 (0%) | .999 |
Dyslipidemia | 6 (2.8%) | 4 (2.0%) | 2 (15.4%) | .005* |
Chronic lung disease | 6 (2.8%) | 6 (3%) | 0 (0%) | .524 |
Allergic rhinitis | 9 (4.3%) | 9 (4.5%) | 0 (0%) | .432 |
Carcinoma | 1 (0.5%) | 1 (0.5%) | 0 (0%) | .797 |
Cardiovascular disease | 2 (0.9%) | 2 (1.0%) | 0 (0%) | .716 |